Adopting a unique approach, and with case studies and examples from developing economy markets, this book integrates science and business to provide an introduction and an insider view of intellectual property issues within the biotech industry. Broad in scope, the book covers key principles in pharmaceutical, industrial and agricultural biotechnology within four sections.
The first section details the principles of intellectual property and biotechnology, the second section covers plant biotechnology, including biotic and abiotic stress tolerance, GM foods in sustainable agriculture, microbial biodiversity and bioprospecting for improving crop health and productivity, and production and regulatory requirements of biopesticides and biofertilizers. The third section describes recent advances in industrial biotechnology, such as DNA patenting, and commercial viability of the CRISPR/Cas9 system in genome editing. The final section describes intellectual property issues in drug discovery and development personalized medicine, and vaccines in biodefense.